Fluoguide AS

Fluoguide AS EBITDA per Employee

EBITDA per Employee of Fluoguide AS (FLUO.ST) as of Oct 25, 2026.

EBITDA per Employee

-DKK

Last updated:

EBITDA per Employee of Fluoguide AS is 2026 - DKK. EBITDA per Employee of Fluoguide AS was 2025 - DKK. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluoguide AS Stock analysis

What does Fluoguide AS do? Fluoguide AS is a clinical stage biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. The company develops surgical solutions using its uPAR technology platform to illuminate cancer cells during surgery, aiming to improve surgical precision and outcomes. Its main product, FG001, targets various cancers including lung, head & neck, meningioma, and low-grade glioma, with the goal of reducing patient pain, enhancing recovery, and lowering healthcare costs. Listed on 7 May 2019, Fluoguide employs eight people. Fluoguide AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluoguide AS stock

On Eulerpool you can find the complete historical development of EBITDA per Employee Fluoguide AS since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's DKK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Fluoguide AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Fluoguide AS

All Key Metrics — Fluoguide AS